H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.7% of adults in Lakewood have diagnosed diabetes — 3.3 points below the U.S. 12% figure. Census population 155,984. Colorado Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lakewood clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lakewood storefront.
Growth Factor Therapy for Tissue Repair in Lakewood, CO for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Lakewood is JH (Novitas Solutions) and that adult diabetes here is 8.7% (PLACES 2023), it is selling units, not a program. That is the growth factor therapy conversation we actually have.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)Colorado shares JH with AR, LA, MS, NM, OK, TX. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 8.7% of adults in Lakewood have diagnosed diabetes — 3.3 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 8.7% of adults in Lakewood have diagnosed diabetes — 3.3 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the growth factor therapy account.
CDC PLACES (2023, crude prevalence) estimates 8.7% of adults — 3.3 points below the U.S. 12% figure. Obesity is 23.8%; arthritis is 24.4%. That is place-level BRFSS modeling, not a clinic census and not a Lakewood trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JH reviewers and surveyors expect — not a brochure.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 8.7% of adults in Lakewood have diagnosed diabetes — 3.3 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Lakewood, CO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lakewood is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Lakewood — 3.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Colorado Part B wound biologics follow this contractor (siblings: AR, LA, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Lakewood. Useful for joint-program math; still needs a diagnosis and privileging.
No Lakewood storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.